Delivery Order SPE2DB24D1021-SPE2DB25FEYLE
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,325,624 units of the prescription medication Alfuzosin HCl ER 10 mg Tablet. The $2,421.58 firm fixed price contract has a period of performance through April 19, 2024 and is not set aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, for the supply of 4,563,589,780 units of the prescription medication Alfuzosin HCl ER 10 mg tablets. The $1,001.74 delivery order has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA...
- This federal contract award, with ID SPE2DB24D1021|SPE2DB24FERQX, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,389.86, is for the delivery of Alfuzosin HCL ER 10 mg tablets. This is a firm fixed-price delivery order contract with a completion date of May 17, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
- The Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order valued at $2,506.72 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 120 tablets of Alfuzosin HCl ER 10 mg. This award is under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and is in effect through December 2025. The contract does not have a set-aside designation and is intended to support military...
- This contract award for $1,415.85 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Alfuzosin HCL ER 10 mg tablets and has an ultimate completion date of October 13, 2023. The contract is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,671.08 for the supply of 4,563,933,249 units of the prescription drug Alfuzosin HCl ER 10 mg tablets. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a firm fixed-price, open-competition delivery order with no set-aside designation. It has an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp holds a significant...
- The Defense Logistics Agency awarded a delivery order valued at $1,367.28 to AmerisourceBergen Drug Corp for Alfuzosin HCL ER 10 mg tablets (90-count supply) on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,878.00, is a Firm Fixed Price Delivery Order for the supply of Alfuzosin HCL ER 10 mg tablets. The award does not utilize any set-aside designation. This contract is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which is...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,183.92 contract is for the supply of Alfuzosin Hydrochloride Extended Release (ER) 10 mg tablets. The order has a completion date of February 26, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $2,848.49 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Alfuzosin HCL ER 10 mg tablets (90-count supply). This competitively awarded, non-set-aside contract features firm fixed pricing and is scheduled for completion by August 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEYLEDelivery Order
This federal contract award is for the delivery of 120 tablets of 10 mg Alfuzosin HCl extended-release tablets to the U.S. Defense Logistics Agency (DLA), a defense agency. The $1,096.04 fixed-price contract was awarded on July 9, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/9/25 |